Sarepta Therapeutics (NASDAQ:SRPT) Price Target Cut to $50.00 by Analysts at Needham & Company LLC
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target decreased by investment analysts at Needham & Company LLC from $125.00 to $50.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target would suggest a potential upside […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target decreased by investment analysts at Needham & Company LLC from $125.00 to $50.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target would suggest a potential upside […]
